Literature DB >> 23419420

Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada.

Jamie R Daw1, Steven G Morgan, Paige A Thomson, Michael R Law.   

Abstract

Canada is the only developed country that has established universal coverage for hospital care and physician services that excludes medically necessary prescription drugs. Lack of public interest in expanding universal coverage to prescription medicines may be one critical factor in explaining this policy puzzle. Historical levels and patterns of attention to financing issues in the media may have implications for public awareness and support for such major health reform. We thus examined the quantity, context, and patterns of coverage of public drug financing in national print media in Canada from 1990 to 2010. We conducted a time series analysis of monthly newspaper article counts to quantify trends in coverage and analyzed article content by applying Down's theory of the "issue-attention cycle" of political attention. We found that baseline coverage of this issue was low throughout the past twenty years with few cycles of increased attention, initiated by focusing events related to general health reform. Issue-attention cycles were driven by coverage of proposed policy solutions simultaneously accompanied by lower levels of coverage of policy problems and barriers to change, before fading rapidly from attention. The observed patterns of media coverage and the intrinsic characteristics of this policy issue suggest that any momentum for reform (or lack thereof) is likely to be driven by elite members of the policy community rather than by way of public engagement. This has implications for the probability of reform and which options may be considered or eventually implemented, as policies developed within elite policy communities may tend to reflect niche interests rather than being reflective of principled policy goals.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23419420     DOI: 10.1016/j.healthpol.2013.01.006

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

1.  National pharmacare: Time to move forward.

Authors:  Leila Salehi
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

2.  [Assurance-médicaments nationale: Le moment d'aller de l'avant].

Authors:  Leila Salehi
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

Review 3.  Universal prescription drug coverage in Canada: Long-promised yet undelivered.

Authors:  Steven G Morgan; Katherine Boothe
Journal:  Healthc Manage Forum       Date:  2016-10-15

4.  Capacity of Kidney Care in Canada: Identifying Barriers and Opportunities.

Authors:  Meaghan Lunney; Arian Samimi; Mohamad A Osman; Kailash Jindal; Natasha Wiebe; Feng Ye; David W Johnson; Adeera Levin; Aminu K Bello
Journal:  Can J Kidney Health Dis       Date:  2019-08-30

5.  Print media coverage of primary healthcare and related research evidence in South Africa.

Authors:  Olagoke Akintola; John N Lavis; Ryan Hoskins
Journal:  Health Res Policy Syst       Date:  2015-11-12

6.  What does the media say about palliative care? A descriptive study of news coverage in written media in Spain.

Authors:  José Miguel Carrasco; Miriam García; Alejandro Navas; Inés Olza; Beatriz Gómez-Baceiredo; Francesc Pujol; Eduardo Garralda; Carlos Centeno
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

Review 7.  Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.

Authors:  Jaden Brandt; Brenna Shearer; Steven G Morgan
Journal:  J Pharm Policy Pract       Date:  2018-11-07

8.  Social representation of palliative care in the Spanish printed media: A qualitative analysis.

Authors:  José Miguel Carrasco; Beatriz Gómez-Baceiredo; Alejandro Navas; Marian Krawczyk; Miriam García; Carlos Centeno
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.